Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 47445 absolute bioavailability, pharmacokinetics, and excretion study in healthy male volunteers
NL-OMON36963Active, not recruiting
- Sponsor
- Servier
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tulrampator in Alzheimer's disease (AD), sponsored by Servier. Primary endpoints: Total radioactivity in plasma, Total radioactivity in urine and 7 more. Started Aug 2012; status: active, not recruiting.
02
Drugs
tulrampator
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON36963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36963.